Markup of
H.R. 965, the “CREATES Act”; H.R. 2375, the “Preserve Access to Affordable Generics and Biosimilars Act”; H.R. 2374, the “Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act”; and H.R. 2376, the “Prescription Pricing for People Act of 2019”.
Committee on the Judiciary
Tuesday, April 30, 2019 (2:00 PM)
2141 RHOB
Washington, D.C.
Text of Legislation
- H.R. 965, the “CREATES Act” (Agreed to by a Voice Vote)
[PDF]
- H.R. 2375, the “Preserve Access to Affordable Generics and Biosimilars Act” (Agreed to by a Voice Vote)
[PDF]
Added
04/29/2019 at 02:19 PM
- H.R. 2374, the “Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act” (Agreed to by a Voice Vote)
[PDF]
Added
04/29/2019 at 02:19 PM
- H.R. 2376, the “Prescription Pricing for People Act of 2019” (Agreed to by a Voice Vote)
[PDF]
Added
04/29/2019 at 02:19 PM
Support Documents
- Letter of Support from AARP
[PDF]
Added
05/01/2019 at 01:25 PM
- Letter of Support from Consumer Reports
[PDF]
Added
05/01/2019 at 01:25 PM
- Letter of Support from Premier Healthcare Alliance
[PDF]
Added
05/01/2019 at 01:25 PM
- Letter of Support from Public Citizen
[PDF]
Added
05/01/2019 at 01:25 PM
Member Statements
- Statement for the Record from Sheila Jackson Lee
[PDF]
Added
05/01/2019 at 01:25 PM
Hearing Record
- Hearing: Member Roster
[PDF]
Added
04/30/2019 at 04:57 PM
- Unofficial Transcript
[PDF]
Added
05/02/2019 at 11:22 AM
First Published:
April 26, 2019 at 03:13 PM
Last Updated:
May 2, 2019 at 11:22 AM